Table 1 Baseline characteristics of 40 patients who underwent robotic colorectal surgery
Characteristic | |
|---|---|
Age (years, mean ± SD) (range) | 60.00 ± 13.22 (32 – 89) |
Gender | |
Female | 21 (52.5 %) |
Male | 19 (47.5 %) |
Tumor size | |
<5 cm | 36 (90.0 %) |
≥5 cm | 4 (10.0 %) |
Tumor size (cm, mean ± SD) (range) | 2.58 ± 1.81 (0 – 8) |
Tumor location | |
Ascending colon | 1 (2.5 %) |
Descending colon | 2 (5.0 %) |
Sigmoid colon | 4 (10.0 %) |
Rectum | 33 (82.5 %) |
Histology | |
Tis | 2 (5.0 %) |
Well | 5 (12.5 %) |
Moderately | 33 (82.5 %) |
AJCC Stagea | |
0 | 7 (17.5 %) |
I | 7 (17.5 %) |
II | 7 (17.5 %) |
III | 14 (35.0 %) |
IV | 5 (12.5 %) |
Tumor depth | |
T0 | 6 (15.0 %) |
Tis | 2 (5.0 %) |
T1 | 3 (7.5 %) |
T2 | 13 (32.5 %) |
T3 | 16 (40.0 %) |
Lymph Node metastasis | |
N0 | 23 (57.5 %) |
N1 | 15 (37.5 %) |
N2 | 2 (5 %) |
Retrieved Lymph Node (median) (range) | |
All patients | 9 (0–22) |
Patients with pre-op CCRTb | 7 (0–16) |
Patients with without pre-op CCRTb | 12 (5–22) |
Vascular invasion | |
No | 31 (77.5 %) |
Yes | 9 (22.5 %) |
Perineural invasion | |
No | 34 (85.0 %) |
Yes | 6 (15.0 %) |
Pre-op serum CEAc level | |
<5 ng/ml | 20 (50.5 %) |
≥5 ng/ml | 20 (50.0 %) |
Post-op serum CEAc level | |
<5 ng/ml | 29 (75.0 %) |
≥5 ng/ml | 11 (25.0 %) |
ASAd classification | |
II | 24 (60.0 %) |
III | 16 (40.0 %) |
Diabetes mellitus | |
Yes | 10 (25.0 %) |
No | 30 (75.0 %) |
BMIe kg/m2 (range) | 23.77 ± 3.86 (17.20 – 34.02) |